<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC6724274\results\search\funders\results.xml">
  <result pre="2163 3825grid.413852.9Centre National de Référence des virus respiratoires France Sud," exact="Hospices Civils de Lyon," post="[4], 0000 0001 2172 4233grid.25697.3fFaculté de Pharmacie, CIRI, Inserm"/>
  <result pre="3825grid.413852.9Laboratory of Bacteriology, Institut des Agents Infectieux, Groupement Hospitalier Nord," exact="Hospices Civils de Lyon," post="[7], 0000 0001 2150 7757grid.7849.2UMR 5558 (EMET). CNRS, LBBE,"/>
  <result pre="subsequent clinical trials. Our population of patients was palivizumab-free. The" exact="American Academy of Pediatrics" post="recommends the use of palivizumab in CF for targeted"/>
  <result pre="infection on lung function in infants with cystic fibrosisPediatrics1999103361962610.1542/peds.103.3.61910049966 28.collab:" exact="American Academy of Pediatrics" post="Committee on Infectious D, American Academy of Pediatrics Bronchiolitis"/>
  <result pre="fibrosisPediatrics1999103361962610.1542/peds.103.3.61910049966 28.collab: American Academy of Pediatrics Committee on Infectious D," exact="American Academy of Pediatrics" post="Bronchiolitis Guidelines CUpdated guidance for palivizumab prophylaxis among infants"/>
 </snippets>
</snippetsTree>
